Bioterma-Širvinta - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 30,270 | 18,100 | 19,800 | 15,400 | 8,930 | 12,600 | 8,060 | 8,020 |
| Profit before tax | 3,351 | -28,256 | 11,838 | 3,034 | 1,982 | 2,191 | 2,604 | 163 |
| Net profit | 3,155 | -28,412 | 11,258 | 2,858 | 1,907 | 2,081 | 2,474 | 153 |
| Equity | 36,884 | 8,472 | 19,730 | 22,588 | 24,495 | 26,576 | 29,050 | 29,203 |
| Liabilities | 152,681 | 110,991 | 109,860 | 110,148 | 109,138 | 87,453 | 87,160 | 87,038 |
| Non-current assets | 2,774 | 753 | 580 | 407 | 233 | 7,708 | 6,040 | 4,430 |
| Current assets | 186,778 | 118,702 | 129,010 | 132,329 | 133,400 | 106,321 | 110,170 | 111,811 |
| Total assets | 189,552 | 119,455 | 129,590 | 132,736 | 133,633 | 114,029 | 116,210 | 116,241 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 0 | 2,242 | 2,460 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -45.8% | -40.2% | +9.4% | -22.2% | -42.0% | +41.1% | -36.0% | -0.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.7% | -23.8% | 8.7% | 2.2% | 1.4% | 1.8% | 2.1% | 0.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 8.6% | -335.4% | 57.1% | 12.7% | 7.8% | 7.8% | 8.5% | 0.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 10.4% | -157.0% | 56.9% | 18.6% | 21.4% | 16.5% | 30.7% | 1.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 11.1% | -156.1% | 59.8% | 19.7% | 22.2% | 17.4% | 32.3% | 2.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.1 | 13.1 | 5.6 | 4.9 | 4.5 | 3.3 | 3.0 | 3.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 30,270 | 18,100 | 19,800 | 15,400 | 8,930 | 12,600 | 8,060 | 8,020 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioterma-Širvinta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-03-05 | 0.13 |
| 2026-01-21 | 2026-02-09 | 0.13 |
| 2025-12-16 | 2025-12-18 | 125.14 |
| 2023-05-16 | 2023-06-07 | 0.05 |
| 2023-05-02 | 2023-05-03 | 0.05 |
| 2023-04-26 | 2023-04-28 | 0.05 |
| 2023-03-16 | 2023-03-19 | 36.33 |
| 2022-07-25 | 2022-08-07 | 0.04 |
| 2022-04-28 | 2022-05-09 | 0.11 |
| 2022-03-16 | 2022-03-17 | 125.14 |
Bioterma-Širvinta - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-12-12 | 2025-12-15 | 0.6 |
| 2025-12-11 | 2025-12-11 | 127.52 |
| 2025-12-09 | 2025-12-10 | 164.47 |
| 2025-12-01 | 2025-12-08 | 164.15 |
| 2025-11-28 | 2025-11-30 | 163.95 |
| 2025-07-29 | 2025-07-29 | 36.76 |
| 2025-07-28 | 2025-07-28 | 516.34 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bioterma-Širvinta, UAB (company code 125923231) is a Private Limited Liability Company engaged in new construction. In 2025, its revenue was €8.0K, broadly flat year on year, after €8.1K in 2024 and €12.6K in 2023. Net profit in 2025 amounted to €153, down sharply from €2.5K in 2024 and €2.1K in 2023, which reduced the profit margin to 1.9% from 30.7% a year earlier. The two-year revenue trend therefore shows a decline, while profitability weakened materially in the latest year. At the same time, the balance sheet remained stable: total assets stood at €116.2K in 2025, equity at €29.2K, and liabilities at €87.0K. Long-term assets decreased to €4.4K, while short-term assets rose to €111.8K. Key ratios indicate modest returns and limited turnover, with ROE at 0.5%, ROA at 0.1%, debt-to-equity at 2.98, and asset turnover at 0.07x. Revenue per employee was €8.0K, while profit per employee was €153.